(Total Views: 469)
Posted On: 01/02/2021 12:19:23 AM
Post# of 145248
I’m of the opinion that the death rate improvement will be less than most on this board thinks .But I also think the secondary endpoints will show overwhelming clinical benefits and ultimately lead to an easy approval ..
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)